Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For many people, the savings justify the minor inconvenience of drawing from a vial rather than using a pre-filled pen
Tirzepatide is the only FDA-approved single-molecule dual agonist for the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
Sustainable Results Unlike some weight loss methods that provide short-term results, tirzepatide has demonstrated the potential for sustained weight loss
Tirzepatide is ideal for adults who are overweight or obese and haven't successfully lost weight through conventional methods
The receptors have downregulated slightly to accommodate the sustained stimulation
Weight loss medication is not considered a permanent solution for weight loss
US$ 29.02
US$ 29.28
US$ 25.72
US$ 26.46
US$ 21.44
US$ 21.43
